2023, Number 2
<< Back Next >>
Dermatología Cosmética, Médica y Quirúrgica 2023; 21 (2)
Trichophyton indotineae: a new challenge in dermatology
García SE, Martínez HE, Acosta AG, Arenas R, Frías LMG
Language: Spanish
References: 20
Page: 168-172
PDF size: 150.70 Kb.
ABSTRACT
In India, in 2018,
Trichophyton indotineae was isolated from a series
of severe cases of tinea corpus and/or tinea cruris (skin lesions
were extensive, highly inflammatory, sometimes pruritic and with
a chronic relapsing course). It was thought that this anthropophilic
fungus was endemic to India, and that the cases reported in other
countries were imported from Asia; however, there are currently
reports of autochthonous cases in different countries such as Germany.
T. indotineae has emerged causing concern in the dermatological
clinical area, since, although it is not a lethal pathogen, it
is easily transmitted from person to person and is usually highly
resistant to terbinafine, one of the first-line antifungal treatments
of dermatophytosis. Furthermore, since it is phylogenetically related
to
T. interdigitale and
T. mentagrophytes, its identification
by conventional phenotypic methods is impossible, therefore molecular
methods are required. Dermatologists must be attentive
to the presence of
T. indotineae to know its local transmission, in
order to provide the most appropriate therapeutic management to
patients, as well as to further elucidate the epidemiology of this
emerging fungus.
REFERENCES
Friedman DZP y Schwartz IS, Emerging fungal infections: newpatients, new patterns, and new pathogens, J Fungi (Basilea) 2019; 5(3):67. Disponible en: https://doi.org/10.3390/jof5030067.
Ghosh A y Panda S, Evidence-based management of dermatophytosisin India today, Apollo Med. Disponible en: https://apollomedicine.org/preprintarticle.asp?id=367276.
Singh A, Masih A, Monroy-Nieto J et al., A unique multidrug-resistantclonal Trichophyton population distinct from Trichophytonmentagrophytes/Trichophyton interdigitale complex causing anongoing alarming dermatophytosis outbreak in India: genomic insightsand resistance profile, Fungal Genet Biol 2019; 133:103266.Disponible en: https://doi.org/10.1016/j.fgb.2019.103266.
Ameen M, Epidemiology of superficial fungal infections, ClinDermatol 2010; 28:197-201. Disponible en: https://doi.org/10.1016/j.clindermatol.2009.12.005.
Kano R, Kimura U, Kakurai M et al., Trichophyton indotineae sp.nov.: a new highly terbinafine-resistant anthropophilic dermatophytespecies, Mycopathologia 2020; 185(6):947-58. Disponibleen: https://doi.org/10.1007/s11046-020-00455-8.
Tang C, Kong X, Ahmed SA et al., Taxonomy of the Trichophytonmentagrophytes/T. interdigitale species complex harboringthe highly virulent, multiresistant genotype T. indotineae, Mycopathologia2021; 186(3):315-26. Disponible en: https://doi.org/10.1007/s11046-021-00544-2.
Jabet A, Brun S, Normand AC et al., Extensive dermatophytosiscaused by terbinafine-resistant Trichophyton indotineae, France,Emerg Infect Dis 2022; 28(1):229-33. Disponible en: https://doi.org/10.3201/eid2801.210883.
Uhrlaß S, Verma SB, Gräser Y et al., Trichophyton indotineae:an emerging pathogen causing recalcitrant dermatophytoses inIndia and worldwide. A multidimensional perspective, J Fungi(Basilea) 2022; 8(7):757. Disponible en: https://doi.org/10.3390/jof8070757.
Chowdhary A, Singh A, Kaur A et al., The emergence and worldwidespread of the species Trichophyton indotineae causing difficult-to-treat dermatophytosis: a new challenge in the managementof dermatophytosis, plos Pathog 2022; 18(9):e1010795.Disponible en: https://doi.org/10.1371/journal.ppat.1010795.
Verma SB, Panda S, Nenoff P et al., The unprecedented epidemic-like scenario of dermatophytosis in India. i. Epidemiology, riskfactors and clinical features, Indian J Dermatol Venereol Leprol2021; 87:154-75. Disponible en: https://doi.org/ 10.25259/IJDVL_301_20.
Nenoff P, Verma SB, Ebert A et al., Spread of terbinafine-resistantTrichophyton mentagrophytes type viii (India) in Germany:“the tip of the iceberg?”, J Fungi (Basilea) 2020; 6: 207. Disponibleen: https://doi.org/ 10.3390/jof6040207.
Dellière S, Joannard B, Benderdouche M et al., Emergence ofdifficult-to-treat tinea corporis caused by Trichophyton mentagrophytescomplex isolates, Paris, France, Emerg InfectDis 2022; 28(1):224-8. Disponible en: https://doi.org/10.3201/eid2801.210810.
Gupta AK, Venkataraman M, Hall DC et al., The emergence ofTrichophyton indotineae: implications for clinical practice, Int JDermatol 2022. Disponible en: https://doi.org/10.1111/ijd.16362.
Posso de los Rios CJ, Tadros E, Summerbell RC et al., Terbinafineresistant Trichophyton indotineae isolated in patientswith superficial dermatophyte infection in Canadian patients, JCutan Med Surg 2022; 26(4):371-6. Disponible en: https://doi.org/10.1177/12034754221077891.
Taghipour S, Shamsizadeh F, Pchelin IM et al., Emergence ofterbinafine resistant Trichophyton mentagrophytes in Iran,harboring mutations in the squalene epoxidase (sqle) gene,Infect Drug Resist 2020; 13:845-50. Disponible en: https://doi.org/10.2147/IDR.S246025.
Normand AC, Moreno-Sabater A, Jabet A et al., maldi-tof massspectrometry online identification of Trichophyton indotineaeusing the msi-2 application, J Fungi (Basilea) 2022; 8:1103. Disponibleen: https://doi.org/10.3390/ jof8101103.
Batvandi A, Pchelin IM, Kiasat N et al., Time and cost-efficientidentification of Trichophyton indotineae, Mycoses 2023;66(1):75–81. Disponible en: https://doi.org/10.1111/myc.13530.
Moreno-Sabater A, Normand AC, Bidaud AL et al., Terbinafineresistance in dermatophytes: a French multicenter prospectivestudy, J Fungi (Basilea) 2022; 8(3):220. Disponible en: https://doi.org/10.3390/jof8030220.
Gawaz A, Nenoff P, Uhrlaß S et al., Treatment of a terbinafineresistantTrichophyton mentagrophytes type viii, Hautarzt 2021;72:900-4. Disponible en: https://doi.org/10.1007/s00105-021-04857-7.
Singh S, Chandra U, Anchan VN et al., Limited effectiveness offour oral antifungal drugs (fluconazole, griseofulvin, itraconazoleand terbinafine) in the current epidemic of altered dermatophytosisin India: results of a randomized pragmatic trial, Br J Dermatol2020; 183:840-6. Disponible en: https://doi.org/10.1111/bjd.19146.